Menu
1 min read · estimated
APPROVED USE
What FDA approved
Patients with metastatic basal cell carcinoma after a hedgehog pathway inhibitor, or when that treatment was inappropriate.
LAMPGEN ANALYSIS
Why it matters
The metastatic indication entered through accelerated approval. FDA granted traditional approval on April 28, 2023.
What research teams should watch
Record metastatic status and keep the 2021 pathway distinct from the later conversion.
PRIMARY RECORDS